Trial Profile
Phase III trial of meldonium (Mildronate) in China in patients with heart failure or ischaemic heart disorders.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 03 Dec 2014
Price :
$35
*
At a glance
- Drugs Meldonium (Primary)
- Indications Heart failure; Ischaemic heart disorders
- Focus Registrational; Therapeutic Use
- Sponsors Grindeks
- 03 Dec 2014 New trial record